Refeyn announces that the company’s Chief Executive Officer, Anthony Fernandez, is stepping down as CEO for health reasons.

Refeyn announces that the company’s Chief Executive Officer, Anthony Fernandez, is taking a temporary leave of absence. During this...

Refeyn Ltd., the mass photometry pioneer, has announced the successful completion of its Series B funding round.

Oxford, UK – 25th November 2020 – UK-based Refeyn Ltd, which develops instrumentation for the disruptive new life science technology mass...

We are pleased to share that Prof. Philipp Kukura (CEO) and Prof. Justin Benesch (Chief Innovation Officer) have been recognised for...